Wolverine Trading
BIB icon

Wolverine Trading’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Wolverine Trading’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,200
Closed -$256K – 4598
2022
Q2 		$256K Buy
+5,200
New +$265K ﹤0.01% 3253
2022
Q1 		– Sell
-6,800
Closed -$561K – 5393
2021
Q4 		$561K Buy
6,800
+1,000
+17% +$85.7K ﹤0.01% 3297
2021
Q3 		$547K Buy
5,800
+2,600
+81% +$263K ﹤0.01% 3810
2021
Q2 		$313K Sell
3,200
-1,800
-36% -$157K ﹤0.01% 4370
2021
Q1 		$397K Buy
+5,000
New +$472K ﹤0.01% 4058
2020
Q4 		– Sell
-4,900
Closed -$340K – 4806
2020
Q3 		$340K Buy
+4,900
New +$348K ﹤0.01% 3241
2019
Q1 		– Sell
-16,100
Closed -$655K – 4525
2018
Q4 		$655K Buy
+16,100
New +$840K ﹤0.01% 2380
2017
Q1 		– Sell
-38,100
Closed -$1.52M – 4251
2016
Q4 		$1.52M Buy
+38,100
New +$1.63M 0.01% 1548
2016
Q3 		– Sell
-30,300
Closed -$1.16M – 4590
2016
Q2 		$1.16M Buy
+30,300
New +$1.31M 0.01% 1479

Other funds holding BIB

CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wolverine Trading's BIB Position: Q1 2017 in Review

Wolverine Trading sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2017, closing a stake of 6,874 shares — an estimated $274K sold.

Wolverine Trading first reported a position in BIB in Q4 2016 and held it in 1 quarter. The position peaked at $274K in Q4 2016. 28 funds tracked by Wall St. Rank hold BIB as of Q1 2017.

  • Wolverine Trading reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2017 after selling out during the quarter.
  • Wolverine Trading sold 6,874 ProShares Ultra NASDAQ Biotechnology shares in Q1 2017, an estimated $274K.
  • Wolverine Trading first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2016 and held it in 1 quarter.
  • Wolverine Trading's ProShares Ultra NASDAQ Biotechnology position peaked at $274K in Q4 2016.
  • 28 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2017.

Based on Wolverine Trading's 13F filing for Q1 2017, filed 15 May 2017.